Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » More articles about Business, Policy & Funding

More articles about Business, Policy & Funding

Sep 21, 2020

Yourgene Inks US Distribution Deal for Chemotoxicity Assay, Other Tests

The deal includes UK-based Yourgene's test for detecting cancer patients who may have an adverse reaction to 5-fluorouracil, as well as reproductive health tests.

Sep 21, 2020

FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

One of the revisions specifies that the ID Now test is for use with specimens collected within the first week of symptom onset.

Sep 18, 2020

Genetics Testing Firm Prenetics Receives $15M Investment From Apis Partners, Alibaba

Prenetics, which operates in 10 countries, will use the funding for R&D and plans to launch a rapid coronavirus nucleic acid test in Q4.

Sep 18, 2020

Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies

The tests will be developed to identify NSCLC patients with ALK fusions and EGFR Exon20 insertion mutations who respond to mobocertinib or brigatinib.

Sep 18, 2020

FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

Visby's test is a fully integrated PCR device that detects SARS-CoV-2 RNA, while SNIBE's test comprises assays for two different antibodies against the virus.

Sep 18, 2020

NCI Awards InheRET $2M SBTT Grant to Improve Inherited Disease Detection

The University of Michigan spinout will use the funds to develop its InheRET platform, increase integration with EHRs, as well as increase its workforce and userbase. 

Sep 17, 2020

CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

The company said it will use the capital to accelerate the growth and development of its infrastructure and CRISPR-based chips.

Sep 17, 2020

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

In 2018 Qiagen purchased a 19.9 percent stake in Ann Arbor, Michigan-based NeuMoDx along with the right to acquire the remaining shares.

Sep 17, 2020

JumpCode Genomics Emerges From Stealth Mode With CRISPR-Based Library Prep Kits

Premium

The company's technology uses CRISPR to deplete unwanted nucleic acid sequences from NGS libraries, leaving behind targets of interest.

Sep 17, 2020

Genetron Health, DMed Enter Pharma Services Partnership

The firms aim to combine their respective products and expertise to provide comprehensive R&D solutions for drug development in oncology.

Sep 17, 2020

Novacyt H1 Revenues Surge on Coronavirus Testing Product Sales

The company's revenues for the first half of the year were up over 900 percent on strong sales of its PCR-based SARS-CoV-2 test and related products.

Sep 17, 2020

DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

The firm's assay is also CE marked for use with nasal swabs, nasopharyngeal swabs, nasal wash and aspirates, and bronchoalveolar lavages.

Sep 16, 2020

Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable

Premium

The company's approach combines whole-genome sequencing, CRISPR, liquid biopsy, and gene therapy to target cancer cells with gene fusions.

Sep 16, 2020

Tiziana Life Sciences to Spin Off StemPrintER Asset Into Separate Company

The company, which originally announced plans for a possible spin off in June, will hold a shareholder meeting to vote on the details in October.

Sep 16, 2020

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

The test is designed to detect and differentiate SARS-CoV-2, influenza A, and influenza B and runs on the company's benchtop Cobas Liat system.

Sep 15, 2020

Seer Spins Out Disease Testing Firm PrognomIQ With $55M in VC Funding

The new company will use Seer's Proteograph proteomic platform along with other omics data to develop and commercialize tests for cancer and other diseases.

Sep 15, 2020

Eurobio Gets CE Mark for Multiplexed SARS-CoV-2, Influenza A/B, RSV Test

The test can be used directly on any open instrument, including portable systems, and it allows for detection of pathogens in about 75 minutes.

Sep 15, 2020

Hexagon Bio Raises $47M in Series A Round

Hexagon's discovery platform is designed to identify potentially therapeutic secondary metabolites and their protein targets from fungal genomes.

Sep 15, 2020

Japanese Startup BitBiome Builds Single-Cell Bacterial Sequencing Services Business

Premium

The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.

Sep 15, 2020

ERS Genomics, Applied StemCell Ink Commercialization Agreement for CRISPR Services, Reagents

Applied StemCell, based in the San Francisco Bay Area, will develop and sell CRISPR-based services and reagents under a license from ERS Genomics.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.